AstraZeneca PLC (AZN) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Astrazeneca Plc.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04248-e1ea-7483-bb9b-2a35bf3b41fc Created: 2026-08-27T08:14:31.184Z Duration: 5903.4907 Channels: 1 00:00:00.000 -- 00:00:01.839 Good morning to those joining from The UK 00:00:01.839 -- 00:00:04.000 and The US. Good afternoon to those in 00:00:04.000 -- 00:00:06.080 Central Europe, and good evening to those listening 00:00:06.080 -- 00:00:07.120 in Asia. 00:00:07.520 -- 00:00:08.960 Welcome to AstraZeneca's 00:00:08.960 -- 00:00:12.080 half one and Q2 2026 webinar for investors 00:00:12.080 -- 00:00:12.880 and analysts. 00:00:13.925 -- 00:00:15.764 Before I hand over to AstraZeneca, 00:00:15.845 -- 00:00:17.845 I'd like to read the safe harbor statement. 00:00:18.805 -- 00:00:20.965 The company intends to utilize the safe harbor 00:00:20.965 -- 00:00:23.685 provisions of The United States Private Securities Litigation 00:00:23.685 -- 00:00:25.605 Reform Act of 1995. 00:00:26.590 -- 00:00:28.670 Participants on this call may make forward looking 00:00:28.670 -- 00:00:31.390 statements with respect to the operations and financial 00:00:31.390 -- 00:00:33.390 performance of AstraZeneca. 00:00:34.430 -- 00:00:36.590 Although we believe our expectations are based on 00:00:36.590 -- 00:00:39.630 reasonable assumptions by their very nature, forward looking 00:00:39.630 -- 00:00:41.550 statements involve risks and uncertainties 00:00:42.035 -- 00:00:43.955 and may be influenced by factors that could 00:00:43.955 -- 00:00:46.435 cause actual results to differ materially from those 00:00:46.435 -- 00:00:49.795 expressed or implied by these forward looking statements. 00:00:50.435 -- 00:00:52.515 Any forward looking statements made on this call 00:00:52.515 -- 00:00:54.995 reflect the knowledge and information avail...